United States Assisted Reproductive Technology (ART) Market

United States Assisted Reproductive Technology (ART) Market Size & Forecast:

• United States Assisted Reproductive Technology (ART) Market Size 2025: USD 6.362 Billion
• United States Assisted Reproductive Technology (ART) Market Size 2033: USD 9.596 Billion 
• United States Assisted Reproductive Technology (ART) Market CAGR: 5.30%
• United States Assisted Reproductive Technology (ART) Market Segments: By Procedure Type (In Vitro Fertilization (IVF), Artificial Insemination, Intracytoplasmic Sperm Injection (ICSI)), By End User (Fertility Clinics, Hospitals).

To learn more about this report,  Download Free Sample Report

United States Assisted Reproductive Technology (ART) Market Summary: 

The United States Assisted Reproductive Technology (ART) market size is estimated at USD 6.362 Billion in 2025 and is anticipated to reach USD 9.596 Billion by 2033, growing at a CAGR of 5.30% from 2026 to 2033. The United States Assisted Reproductive Technology (ART) market is expanding at a stable pace because both infertility rates have increased and people are having children later in life, and society now accepts fertility treatments. Medical technological advancements, which include IVF and genetic screening, have increased both treatment success rates and patient health results. The presence of supportive regulations together with growing public awareness has resulted in more couples and individuals pursuing medical treatment. Clinics establish personalised treatment methods which enhance patient access to medical services, and this development continues to boost market growth.

Key Market Trends & Insights: 

• Individuals and couples tend to delay family beginnings until later life because they prioritise their professional obligations and financial needs. The natural decline of fertility with ageing has resulted in increased dependence on ART procedures, which include IVF treatments.

• Treatment precision is being improved through genetic testing and embryo freezing and time-lapse imaging technologies. The new technologies enable clinics to achieve better treatment outcomes while decreasing the emotional and financial burden on patients.
• Urban and suburban regions are seeing an increase in the establishment of specialised fertility centres. The comprehensive service model which clinics provide at their locations enhances both convenience and patient satisfaction.

• States and employers are expanding their insurance plans to cover more fertility treatment options. Although ART coverage differs among health plans, the financial assistance enables more people to access ART services.

• Single individuals and same-sex couples increasingly turn to ART services for their family needs. Clinics are enhancing their service offerings to create a more inclusive environment which helps different family-building paths.

United States Assisted Reproductive Technology (ART) Market Segmentation

By Procedure Type

• In Vitro Fertilization (IVF): The United States health system currently uses in vitro fertilisation (IVF) as its most popular assisted reproductive technology method, which provides assistance to people who face challenges with infertility. The process requires scientists to create human embryos through laboratory fertilisation, which they later transfer into a woman's uterus for implantation. The current advancements in laboratory methods, together with better techniques for selecting embryos, are resulting in improved success rates of treatments which boost patient trust.

• Artificial Insemination: The medical procedure of artificial insemination provides patients with a safe and cost-effective choice which achieves better results than other assisted reproductive technology procedures. The process requires doctors to insert sperm directly into a woman's uterus at the time when she ovulates. The medical procedure serves as a standard initial treatment because it effectively addresses mild fertility problems together with clients who want to become parents without partners.

• Intracytoplasmic Sperm Injection (ICSI): It stands for a type of in vitro fertilisation which allows the physician to literally inject one sperm cell into one egg cell. The technique proves most beneficial for diagnosing and treating male fertility problems. ICSI serves as an essential treatment method because it provides couples with complex fertility issues precise solutions to their reproductive problems.

To learn more about this report,  Download Free Sample Report

By End User

• Fertility Clinics: Fertility clinics provide ART services through their specialised medical treatment and technologically advanced treatment facilities. The centres provide dedicated reproductive healthcare services which develop customised medical solutions for patients. The clinic provides advanced fertility treatment solutions because its staff members possess expertise and its facilities include modern technologies.

• Hospitals: Hospitals provide essential support for ART services through their specialised medical teams who treat patients with multiple health conditions. The centre provides complete medical services through its extensive network of doctors who serve various medical specialities. Hospitals are the preferred choice for patients with complicated medical situations who need specialised medical monitoring and advanced hospital facilities.

Country Insights

The United States Assisted Reproductive Technology (ART) market shows a dynamic combination of medical progress and changing social behaviours and healthcare systems that provide support. The country experiences rising demand for fertility treatments because more people choose to postpone starting their families. The United States attracts international patients who need ART services because advanced fertility clinics and expert physicians and modern medical equipment exist within its borders. 

The rising public understanding of infertility together with open discussions about the condition has led to more people searching for urgent medical assistance. The insurance situation varies between states, yet employer-sponsored programmes are becoming better at helping people access these medical services. The market receives advantages from research and development activities which create better treatment methods that result in higher success rates and increased patient safety. The U.S. ART field uses a combination of patient-focused methods and inclusive practices and innovative methods to make fertility treatment more accessible to various patient groups.

Recent Development News

IVF Birth Rates Rising Across U.S. Regions: IVF usage is increasing significantly, especially in urban areas where delayed parenthood is common. Experts link this trend to better access, higher income levels, and expanded fertility benefits. 

U.S. Government Pushes to Reduce IVF Costs: Federal efforts are underway to lower IVF drug prices and improve access. The initiative includes direct-to-consumer drug platforms and employer benefit flexibility. 

Key United States Assisted Reproductive Technology (ART) Company Insights

The United States Assisted Reproductive Technology (ART) market operates through established fertility networks and new specialised medical facilities. Companies are focusing on advanced technologies, which include genetic screening and cryopreservation, to enhance their success rates and improve patient results. Many providers are expanding their clinic networks to serve a broader patient base. Service providers now use partnerships and acquisitions together with digital health systems to improve their service delivery. Companies develop more accessible fertility treatment systems through their dedication to personalised patient care and enhanced treatment experiences.

Company List

• Vitrolife AB
• CooperSurgical Inc.
• Cook Medical Inc.
• Genea Biomedx
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Ferring Pharmaceuticals
• Progyny Inc.
• OvaScience Inc.
• Irvine Scientific Inc.
• Hamilton Thorne Ltd.
• Rocket Medical PLC
• EMD Serono Inc.
• IVFtech ApS
• Nidacon International AB

United States Assisted Reproductive Technology (ART) Market Report Segmentation

By Procedure Type

• In Vitro Fertilization (IVF)
• Artificial Insemination
• Intracytoplasmic Sperm Injection (ICSI)

By End User

• Fertility Clinics
• Hospitals